chevron-down Created with Sketch Beta.
May 13, 2022

DOJ Subpoenas Telehealth Company for Potential Overprescribing of Stimulants

Prosecutors with the U.S. Attorney’s Office for the Eastern District of New York have served Cerebral, a telehealth company that treats attention deficit hyperactivity disorder, with a grand jury subpoena relating to an investigation into possible violations of the Controlled Substances Act. The subpoena was directed to Cerebral Medical Group, a contractor that provides healthcare services on behalf of Cerebral.

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.